Ensysce completes enrollment in final stage of opioid study

Go back to Ensysce completes enrollment in final stage of opioid study
(NASDAQ: ENSC) Delayed: 0.42 --0 (-0%)
Previous Close $0.42    52 Week High
Open $0.42    52 Week Low
Day High $0.42    P/E N/A 
Day Low $0.42    EPS
Volume 4,779